Cargando…
Tumors of the Central Nervous System, Volume 2 Gliomas: Glioblastoma (Part 2) /
Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in m...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2011.
|
| Edición: | 1st ed. 2011. |
| Colección: | Tumors of the Central Nervous System,
2 |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-94-007-0618-7 | ||
| 003 | DE-He213 | ||
| 005 | 20230730021601.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 110815s2011 ne | s |||| 0|eng d | ||
| 020 | |a 9789400706187 |9 978-94-007-0618-7 | ||
| 024 | 7 | |a 10.1007/978-94-007-0618-7 |2 doi | |
| 050 | 4 | |a RC261-271 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 571.978 |2 23 |
| 082 | 0 | 4 | |a 616.994 |2 23 |
| 245 | 1 | 0 | |a Tumors of the Central Nervous System, Volume 2 |h [electronic resource] : |b Gliomas: Glioblastoma (Part 2) / |c edited by M.A. Hayat. |
| 250 | |a 1st ed. 2011. | ||
| 264 | 1 | |a Dordrecht : |b Springer Netherlands : |b Imprint: Springer, |c 2011. | |
| 300 | |a XXII, 458 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Tumors of the Central Nervous System, |x 2215-0978 ; |v 2 | |
| 520 | |a Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. | ||
| 650 | 0 | |a Cancer. | |
| 650 | 0 | |a Nervous system-Radiography. | |
| 650 | 0 | |a Nervous system-Surgery. | |
| 650 | 0 | |a Oncology. | |
| 650 | 0 | |a Pathology. | |
| 650 | 0 | |a Surgery. | |
| 650 | 1 | 4 | |a Cancer Biology. |
| 650 | 2 | 4 | |a Neuroradiology. |
| 650 | 2 | 4 | |a Neurosurgery. |
| 650 | 2 | 4 | |a Oncology. |
| 650 | 2 | 4 | |a Pathology. |
| 650 | 2 | 4 | |a Surgery. |
| 700 | 1 | |a Hayat, M.A. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789400735804 |
| 776 | 0 | 8 | |i Printed edition: |z 9789400706170 |
| 776 | 0 | 8 | |i Printed edition: |z 9789400706194 |
| 830 | 0 | |a Tumors of the Central Nervous System, |x 2215-0978 ; |v 2 | |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-94-007-0618-7 |z Texto Completo |
| 912 | |a ZDB-2-SME | ||
| 912 | |a ZDB-2-SXM | ||
| 950 | |a Medicine (SpringerNature-11650) | ||
| 950 | |a Medicine (R0) (SpringerNature-43714) | ||